Overview: PSA Recurrent Prostate Cancer

The video provides a comprehensive and clinically relevant overview of PSA-recurrent prostate cancer, delivered by an experienced radiation oncologist. The content is well-structured, covering definitions, risk factors, evaluation, and treatment options. The speaker effectively integrates current guidelines (e.g., AUA) and modern imaging techniques, particularly PSMA PET, which is now standard. The discussion of treatment scenarios is practical and nuanced, acknowledging the complexity of decision-making in this patient population. The speaker appropriately emphasizes the importance of patient factors such as life expectancy and quality of life, and he is transparent about his personal practice patterns, which adds credibility. However, the presentation is primarily an expert opinion and lacks detailed citations to specific studies or clinical trials. While the information aligns with current evidence, the absence of references limits the ability to verify specific claims. The speaker also touches on controversial topics, such as the use of genomic classifiers (e.g., Decipher) and the timing of salvage therapy, without delving into the supporting data. The video is suitable for healthcare professionals and informed patients, but it may be too technical for a general audience. The adéquation between title and content is excellent, as the talk indeed provides an overview of the topic. Overall, the video is a valuable educational resource, but viewers should seek additional sources for detailed evidence and guidelines.

The title accurately reflects the content, which provides a comprehensive overview of PSA-recurrent prostate cancer, including definitions, risk factors, evaluation, and treatment scenarios.

8/10

The video features multiple experts from a reputable academic institution (UCSF) discussing evidence-based approaches to PSA-recurrent prostate cancer. The content aligns with current clinical guidelines and includes references to imaging modalities and treatment options. However, it is primarily an expert opinion presentation without detailed citations or peer-reviewed data, and some statements are based on personal practice patterns.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 00:00Introduction and goals of the talk
• 01:00Definition of PSA recurrence after surgery and radiation
• 03:00Risk factors for recurrence: extraprostatic extension, seminal vesicle invasion, positive margins, Gleason score, PSA nadir
• 06:00Evaluation approach: life expectancy, patient preferences, urinary and erectile function, PSA doubling time, imaging
• 09:00Role of PET scans, especially PSMA PET, in detecting small-volume disease
• 12:00Scenario 1: Post-surgery PSA recurrence with low PSA, treatment with salvage radiation to surgical bed
• 15:00Considerations for adding pelvic radiation and androgen deprivation based on PSA level and risk factors
• 18:00Scenario 2: Positive pelvic lymph node, treatment with whole pelvic radiation and ADT
• 21:00Scenario 3: Limited life expectancy or prior pelvic radiation, use of SBRT to involved nodes
• 24:00Scenario 4: Local recurrence after radiation, options including brachytherapy, focal therapy, SBRT, and salvage prostatectomy

• UCTV Health & Medicine — General health and medicine content from University of California medical schools.
• Prostate Cancer Patient Conference — Series of talks from the Prostate Cancer Patient Conference, including this presentation.
• UCTV Main Website — Broadcast and online media platform of the University of California.

• AUA Guidelines on Prostate Cancer — Guidelines referenced for definitions and treatment recommendations.